Anti-GILT antibody [EPR30714-572]
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal GILT antibody. Suitable for ICC/IF, IHC-P, WB and reacts with Human samples.
View Alternative Names
GILT, IP30, IFI30, Gamma-interferon-inducible lysosomal thiol reductase, Gamma-interferon-inducible protein IP-30, Legumaturain
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-GILT antibody [EPR30714-572] (AB325920)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized Raji (human Burkitt's lymphoma B lymphocyte) IMR-32 (human neuroblastoma neuroblast) cells labelling GILT with ab325920 at 1/500 (0.968 µg/ml) dilution , followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 dilution (Green).
Confocal image showing staining in Raji cell line (green). The counterstain was observed in magenta. Nuclear DNA was labelled with DAPI (shown in blue). Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8). Low expression : IMR-32.
ab7291 Anti-alpha Tubulin mouse monoclonal antibody was used to counterstain tubulin at 1/1000 dilution (Magenta). The Nuclear counterstain was DAPI (Blue).
-ve control 1 : ab325920 at 1/500 dilution, followed by ab150120 at 1/1000 dilution.-ve control 2 : ab7291 at 1/1000 dilution, followed by ab150081 at 1/1000 dilution.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GILT antibody [EPR30714-572] (AB325920)
Immunohistochemical analysis of paraffin-embedded Human liver cancer tissue labeling GILT with ab325920 at 1/5000 (0.097 µg/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining on stromal cells of human liver cancer.
The primary antibody was incubated for 10 mins at room temperature, Incubate slides with 3% Hydrogen Peroxide for 10 mins at room temperature after secondary antibody incubation to reduce the background.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Citrate buffer (pH 6.0, Epitope Retrieval Solution 1) for 20 mins
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GILT antibody [EPR30714-572] (AB325920)
Immunohistochemical analysis of paraffin-embedded Human breast cancer tissue labeling GILT with ab325920 at 1/5000 (0.097 µg/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining on human breast cancer (PMID : 34648659).
The primary antibody was incubated for 10 mins at room temperature, Incubate slides with 3% Hydrogen Peroxide for 10 mins at room temperature after secondary antibody incubation to reduce the background.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Citrate buffer (pH 6.0, Epitope Retrieval Solution 1) for 20 mins
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GILT antibody [EPR30714-572] (AB325920)
Immunohistochemical analysis of paraffin-embedded (A) : Raji (human Burkitt's lymphoma B lymphocyte) cell pellet (B) : IMR-32 (human neuroblastoma neuroblast) cell pellet tissue labeling GILT with ab325920 at 1/1000 (0.484 µg/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining on Raji cell pellet, no staining on IMR-32 cell pellet.
The primary antibody was incubated for 10 mins at room temperature, Incubate slides with 3% Hydrogen Peroxide for 10 mins at room temperature after secondary antibody incubation to reduce the background.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Citrate buffer (pH 6.0, Epitope Retrieval Solution 1) for 20 mins
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GILT antibody [EPR30714-572] (AB325920)
Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labeling GILT with ab325920 at 1/5000 (0.097 µg/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining on human tonsil (PMID : 24409177).
The primary antibody was incubated for 10 mins at room temperature, Incubate slides with 3% Hydrogen Peroxide for 10 mins at room temperature after secondary antibody incubation to reduce the background.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Citrate buffer (pH 6.0, Epitope Retrieval Solution 1) for 20 mins
- WB
Lab
Western blot - Anti-GILT antibody [EPR30714-572] (AB325920)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : skeletal muscle.
The weak band observed at ~35KDa may represent the precursor form of GILT (PMID : 39273610).
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) (1 : 200000) (36KDa).
All lanes:
Western blot - Anti-GILT antibody [EPR30714-572] (ab325920) at 1/1000 dilution
Lane 1:
Human liver tissue lysate at 20 µg
Lane 2:
Human breast cancer tissue lysate at 20 µg
Lane 3:
Human lung tissue lysate at 20 µg
Lane 4:
Human spleen tissue lysate at 20 µg
Lane 5:
Human lymph node tissue lysate at 20 µg
Lane 6:
Human tonsil tissue lysate at 50 µg
Lane 7:
Human lung tissue lysate at 50 µg
Lane 8:
Human skeletal muscle tissue lysate at 50 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 28 kDa,35 kDa,36 kDa
false
Exposure time: 3s
- WB
Lab
Western blot - Anti-GILT antibody [EPR30714-572] (AB325920)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : IMR-32, SK-N-BE(2).
The weak band observed at ~35KDa may represent the precursor form of GILT (PMID : 39273610).
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-GILT antibody [EPR30714-572] (ab325920) at 1/1000 dilution
Lane 1:
Raji (human Burkitt's lymphoma B lymphocyte) whole cell lysate at 20 µg
Lane 2:
IMR-32 (human neuroblastoma neuroblast) whole cell lysate at 20 µg
Lane 3:
SK-N-BE(2) (human neuroblastoma neuroblast) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 28 kDa,35 kDa,124 kDa
false
Exposure time: 3s
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GILT antibody [EPR30714-572] (AB325920)
Immunohistochemical analysis of paraffin-embedded Human skeletal muscle tissue labeling GILT with ab325920 at 1/5000 (0.097 µg/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Negative control : no staining on human skeletal muscle.
The primary antibody was incubated for 10 mins at room temperature, Incubate slides with 3% Hydrogen Peroxide for 10 mins at room temperature after secondary antibody incubation to reduce the background.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Citrate buffer (pH 6.0, Epitope Retrieval Solution 1) for 20 mins
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com